NCT07012031 2026-03-17
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
National Cancer Institute (NCI)
Phase 1/2 Recruiting
National Cancer Institute (NCI)
Amgen
Hoffmann-La Roche
M.D. Anderson Cancer Center
City of Hope Medical Center
Fundación GECP
Radboud University Medical Center
Vestre Viken Hospital Trust
Erasca, Inc.